Matches in SemOpenAlex for { <https://semopenalex.org/work/W4281569134> ?p ?o ?g. }
Showing items 1 to 88 of
88
with 100 items per page.
- W4281569134 abstract "Abstract Background The cardiovascular and renal benefits of sodium glucose co-transporter 2 inhibitors (SGLT2i) have been clearly demonstrated. However, studies comparing the effects of dapagliflozin and empagliflozin are scarce. Therefore, we aimed to compare the clinical outcomes between dapagliflozin and empagliflozin in patients with type 2 diabetes without prior atherosclerotic cardiovascular disease, chronic kidney disease, or heart failure. Methods Using a propensity-score matching method, we retrospectively analyzed 921 patients treated with dapagliflozin, 921 patients treated with empagliflozin, and 1842 patients treated with dipeptidyl peptidase-4 inhibitors (DPP4i; control group). Study outcomes comprised composite coronary events (acute coronary syndrome and coronary revascularization), composite ischemic events (coronary events and stroke), and composite heart failure and renal events. Results During follow up (median, 43.4 months), the incidence of composite coronary events was significantly lower in the SGLT2i groups than in the control group, and the incidence of composite ischemic events was lower in the dapagliflozin group than in the control group. Dapagliflozin and empagliflozin both demonstrated significant benefits in terms of heart failure and renal outcomes, supported by renoprotective effects, as assessed by the change in glomerular filtration rate. At 24–36 months of treatment, the empagliflozin group had higher low-density lipoprotein cholesterol levels, and lower glycated hemoglobin levels, compared to those in the dapagliflozin and control groups. Conclusion SGLT2i use was associated with a significantly reduced risk of atherosclerotic cardiovascular events, heart failure hospitalization, and renal events, compared to that with DPP4i use. There were no significant differences in clinical outcomes between dapagliflozin and empagliflozin, supporting a SGLT2i class effect." @default.
- W4281569134 created "2022-05-27" @default.
- W4281569134 creator A5027441333 @default.
- W4281569134 creator A5033244316 @default.
- W4281569134 creator A5041753385 @default.
- W4281569134 creator A5070061558 @default.
- W4281569134 date "2022-05-25" @default.
- W4281569134 modified "2023-09-29" @default.
- W4281569134 title "Comparison of cardiovascular and renal outcomes between dapagliflozin and empagliflozin in patients with type 2 diabetes" @default.
- W4281569134 cites W2146264128 @default.
- W4281569134 cites W2147663252 @default.
- W4281569134 cites W2884144220 @default.
- W4281569134 cites W2884466498 @default.
- W4281569134 cites W2899764361 @default.
- W4281569134 cites W2900413769 @default.
- W4281569134 cites W2914038117 @default.
- W4281569134 cites W2927285401 @default.
- W4281569134 cites W2939222610 @default.
- W4281569134 cites W2973090108 @default.
- W4281569134 cites W2974260792 @default.
- W4281569134 cites W2975677680 @default.
- W4281569134 cites W2976129020 @default.
- W4281569134 cites W2990869853 @default.
- W4281569134 cites W3032446134 @default.
- W4281569134 cites W3049755143 @default.
- W4281569134 cites W3092379111 @default.
- W4281569134 cites W3093526502 @default.
- W4281569134 cites W3135562266 @default.
- W4281569134 cites W3185500705 @default.
- W4281569134 cites W3209125166 @default.
- W4281569134 cites W3210044928 @default.
- W4281569134 cites W3210357221 @default.
- W4281569134 cites W3213347026 @default.
- W4281569134 cites W4206549973 @default.
- W4281569134 cites W4212810717 @default.
- W4281569134 doi "https://doi.org/10.1101/2022.05.23.22275457" @default.
- W4281569134 hasPublicationYear "2022" @default.
- W4281569134 type Work @default.
- W4281569134 citedByCount "2" @default.
- W4281569134 countsByYear W42815691342022 @default.
- W4281569134 crossrefType "posted-content" @default.
- W4281569134 hasAuthorship W4281569134A5027441333 @default.
- W4281569134 hasAuthorship W4281569134A5033244316 @default.
- W4281569134 hasAuthorship W4281569134A5041753385 @default.
- W4281569134 hasAuthorship W4281569134A5070061558 @default.
- W4281569134 hasBestOaLocation W42815691341 @default.
- W4281569134 hasConcept C126322002 @default.
- W4281569134 hasConcept C127413603 @default.
- W4281569134 hasConcept C134018914 @default.
- W4281569134 hasConcept C159641895 @default.
- W4281569134 hasConcept C164705383 @default.
- W4281569134 hasConcept C2775887513 @default.
- W4281569134 hasConcept C2777180221 @default.
- W4281569134 hasConcept C2777422806 @default.
- W4281569134 hasConcept C2778198053 @default.
- W4281569134 hasConcept C2780645631 @default.
- W4281569134 hasConcept C555293320 @default.
- W4281569134 hasConcept C71924100 @default.
- W4281569134 hasConcept C78519656 @default.
- W4281569134 hasConceptScore W4281569134C126322002 @default.
- W4281569134 hasConceptScore W4281569134C127413603 @default.
- W4281569134 hasConceptScore W4281569134C134018914 @default.
- W4281569134 hasConceptScore W4281569134C159641895 @default.
- W4281569134 hasConceptScore W4281569134C164705383 @default.
- W4281569134 hasConceptScore W4281569134C2775887513 @default.
- W4281569134 hasConceptScore W4281569134C2777180221 @default.
- W4281569134 hasConceptScore W4281569134C2777422806 @default.
- W4281569134 hasConceptScore W4281569134C2778198053 @default.
- W4281569134 hasConceptScore W4281569134C2780645631 @default.
- W4281569134 hasConceptScore W4281569134C555293320 @default.
- W4281569134 hasConceptScore W4281569134C71924100 @default.
- W4281569134 hasConceptScore W4281569134C78519656 @default.
- W4281569134 hasLocation W42815691341 @default.
- W4281569134 hasOpenAccess W4281569134 @default.
- W4281569134 hasPrimaryLocation W42815691341 @default.
- W4281569134 hasRelatedWork W2807204184 @default.
- W4281569134 hasRelatedWork W3040668198 @default.
- W4281569134 hasRelatedWork W3047126662 @default.
- W4281569134 hasRelatedWork W3088393838 @default.
- W4281569134 hasRelatedWork W3104942557 @default.
- W4281569134 hasRelatedWork W3143290529 @default.
- W4281569134 hasRelatedWork W3183987707 @default.
- W4281569134 hasRelatedWork W3208638507 @default.
- W4281569134 hasRelatedWork W4210427521 @default.
- W4281569134 hasRelatedWork W4225666519 @default.
- W4281569134 isParatext "false" @default.
- W4281569134 isRetracted "false" @default.
- W4281569134 workType "article" @default.